FDA Adverse Event Injury Summary report: N

SIGMA PS CEM FEM SZ3 R

MDR report key: 6233926 · Received January 9, 2017

Report

Report Number
1818910-2017-10438
Event Type
Injury
Date Received
January 9, 2017
Date of Event
January 4, 2017
Report Date
January 4, 2017
Product Code
JWH
PMA / PMN Number
K032151
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4). THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. A WORLDWIDE COMPLAINT DATABASE SEARCH FOUND ONE OTHER REPORTED INCIDENT(S) AGAINST 3102080 SMARTSET MV ENDURANCE 80G. A PREVIOUS DHR FOUND NO RELATED DEVIATIONS OR ANOMALIES. A WORLDWIDE COMPLAINT DATABASE SEARCH FOUND NO OTHER REPORTED INCIDENT(S) AGAINST THE REMAINING PROVIDED PRODUCT/LOT COMBINATION(S) SINCE RELEASE FOR DISTRIBUTION. BASED ON PREVIOUS INVESTIGATIONS THIS COMPLICATION OF JOINT REPLACEMENT IS UNLIKELY TO HAVE BEEN THE RESULT OF A DEVICE FAILING TO MEET REQUIRED SPECIFICATIONS. THE INFORMATION RECEIVED WILL BE RETAINED FOR POTENTIAL SERIES INVESTIGATIONS IF TRIGGERED BY TREND ANALYSIS, POST MARKET SURVEILLANCE, OR OTHER EVENTS WITHIN THE QUALITY SYSTEM. CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS TIBIAL AND FEMORAL LOOSENING. LOOSENING OCCURRED AT THE BONE/CEMENT AND CEMENT/IMPLANT INTERFACE. CEMENT MANUFACTURED BY DEPUY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
15288 SIGMA PS CEM FEM SZ3 R KNEE FEMORAL COMPONENT JWH DL1AD4

Patients

Seq Age Sex Outcome Treatment
1 78 YR Required Intervention